Stay updated on GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Sign up to get notified when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.

Latest updates to the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check38 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 31, 2025.SummaryDifference1.0%
- Check81 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check95 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check103 days agoChange DetectedThe study on the safety and tolerability of GTX-102 in children with Angelman Syndrome has been completed and updated to revision v2.14.2, replacing the previous active status and earlier revision.SummaryDifference2%
Stay in the know with updates to GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.